These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23578916)

  • 21. Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?
    Wiesener S; Salamonsen A; Fønnebø V
    BMC Complement Altern Med; 2018 Jan; 18(1):11. PubMed ID: 29321023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementary and alternative medicine in pediatrics in Turkey.
    Ozturk C; Karatas H; Längler A; Schütze T; Bailey R; Zuzak TJ
    World J Pediatr; 2014 Nov; 10(4):299-305. PubMed ID: 25515802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research into complementary and alternative medicine across Europe and the United States.
    Giovannini P; Schmidt K; Canter PH; Ernst E
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11(4):224-30. PubMed ID: 15347905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q).
    Quandt SA; Verhoef MJ; Arcury TA; Lewith GT; Steinsbekk A; Kristoffersen AE; Wahner-Roedler DL; Fønnebø V
    J Altern Complement Med; 2009 Apr; 15(4):331-9. PubMed ID: 19388855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Then I went to a hospital abroad": acknowledging implications of stakeholders' differing risk understandings related to use of complementary and alternative medicine in European health care contexts.
    Salamonsen A; Wiesener S
    BMC Complement Altern Med; 2019 Apr; 19(1):93. PubMed ID: 31039772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe.
    Salomone E; Charman T; McConachie H; Warreyn P;
    Eur J Pediatr; 2015 Oct; 174(10):1277-85. PubMed ID: 25855095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary and alternative medicine used by children in military pediatric clinics.
    Huillet A; Erdie-Lalena C; Norvell D; Davis BE
    J Altern Complement Med; 2011 Jun; 17(6):531-7. PubMed ID: 21649519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of complementary and alternative medicine (CAM) in children: a telephone-based survey in Korea.
    Kim JH; Nam CM; Kim MY; Lee DC
    BMC Complement Altern Med; 2012 Apr; 12():46. PubMed ID: 22515558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey.
    Yeh GY; Eisenberg DM; Davis RB; Phillips RS
    Am J Public Health; 2002 Oct; 92(10):1648-52. PubMed ID: 12356615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and co-occurrence of types of complementary and alternative medicine use by age, gender, ethnicity, and education among adults in the United States: the 2002 National Health Interview Survey (NHIS).
    Neiberg RH; Aickin M; Grzywacz JG; Lang W; Quandt SA; Bell RA; Arcury TA
    J Altern Complement Med; 2011 Apr; 17(4):363-70. PubMed ID: 21495904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical Pluralism in East and West Europe: A Comparison of People Visiting Healthcare Practitioners Specializing in Complementary and Alternative Medicine.
    Souček I; Hofreiter R
    Complement Med Res; 2022; 29(4):297-308. PubMed ID: 35350023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of complementary and alternative medicine (CAM) among children from a German birth cohort (GINIplus): patterns, costs, and trends of use.
    Italia S; Brand H; Heinrich J; Berdel D; von Berg A; Wolfenstetter SB
    BMC Complement Altern Med; 2015 Mar; 15():49. PubMed ID: 25885673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot feasibility study of a questionnaire to determine European Union-wide CAM use.
    Eardley S; Bishop FL; Cardini F; Santos-Rey K; Jong MC; Ursoniu S; Dragan S; Hegyi G; Uehleke B; Vas J; Jupaneant O; Citro MC; Fønnebø V; Quandt SA; Lewith G
    Forsch Komplementmed; 2012; 19(6):302-10. PubMed ID: 23343585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary and Alternative Medicine (CAM) in paediatric rheumatology: a European perspective.
    Fadanelli G; Vittadello F; Martini G; Zannin ME; Zanon G; Zulian F
    Clin Exp Rheumatol; 2012; 30(1):132-6. PubMed ID: 22325053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys.
    Posadzki P; Lee MS; Moon TW; Choi TY; Park TY; Ernst E
    Maturitas; 2013 May; 75(1):34-43. PubMed ID: 23497959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants.
    Kemppainen LM; Kemppainen TT; Reippainen JA; Salmenniemi ST; Vuolanto PH
    Scand J Public Health; 2018 Jun; 46(4):448-455. PubMed ID: 28975853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of complementary/alternative medicine for children: a systematic review.
    Ernst E
    Eur J Pediatr; 1999 Jan; 158(1):7-11. PubMed ID: 9950300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors of complementary and alternative medicine use in the general population in Europe: A systematic review.
    Guillaud A; Darbois N; Allenet B; Pinsault N
    Complement Ther Med; 2019 Feb; 42():347-354. PubMed ID: 30670265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of complementary and alternative medicine in pediatric otolaryngology patients attending a tertiary hospital in the UK.
    Shakeel M; Little SA; Bruce J; Ah-See KW
    Int J Pediatr Otorhinolaryngol; 2007 Nov; 71(11):1725-30. PubMed ID: 17714796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.